Posted on January 27, 20211/27/21
Senate Finance Committee Report on Rising Insulin Costs Criticizes Industry, PBM Practices
Posted on January 4, 20211/4/21
China Issues 2020 National Reimbursement Drug List
Posted on December 18, 202012/18/20
Japan’s First Off-Year Re-Pricing to Impact 70% of All NHI-Listed Medicines
Posted on October 7, 202010/7/20
EMA Commences Rolling Review of Second COVID-19 Vaccine
Posted on September 14, 20209/14/20
German Payer GKV-SV Concerned Over Added Value of Health Apps
Posted on June 15, 20206/15/20
Japan Pharma Association Introduces Bold Policy Measures to Reform Sector
Posted on May 6, 20205/6/20
Biosimilars Saved Spain 2,400 Million Euros Between 2009 and 2020
Posted on February 23, 20202/23/20
FDA Publishes Final Rule on New Regulatory Pathway Shift for Insulin, Other Biologics
Posted on January 6, 20201/6/20